Alembic Pharmaceuticals Ltd receives EIR from USFDA for facility at Panelav

Alembic Pharmaceuticals Limited has received Establishment Inspection Report (EIR) today for the inspection carried out by the US Food and Drug Administration (USFDA) at our API - I & API - II Facility located at Panelav. The inspection was conducted from 26th May, 2025 to 31st May, 2025.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 945.80 as compared to the previous close of Rs. 946.40. The total number of shares traded during the day was 3208 in over 236 trades.

The stock hit an intraday high of Rs. 961.85 and intraday low of 936.00. The net turnover during the day was Rs. 3047130.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 EIR USFDA APIFacility Panelav